Pharmaceutical Fluid Handling

Global Pharmaceutical Fluid Handling Market to Reach US$13.8 Billion by 2030

The global market for Pharmaceutical Fluid Handling estimated at US$11.5 Billion in the year 2024, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Equipment & Solutions Offering, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$7.9 Billion by the end of the analysis period. Growth in the Services Offering segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 5.7% CAGR

The Pharmaceutical Fluid Handling market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Pharmaceutical Fluid Handling Market - Key Trends & Drivers Summarized

Why Is Fluid Handling So Critical to Drug Manufacturing Efficiency and Safety?

Pharmaceutical fluid handling encompasses systems and components used to transfer, mix, store, and dispense liquids during drug production. It plays a key role in maintaining product sterility, formulation consistency, and process efficiency across both batch and continuous manufacturing environments. These systems are critical for handling active pharmaceutical ingredients (APIs), solvents, buffer solutions, and biological fluids.

A wide range of equipment is used, including pumps, valves, hoses, tubing, mixers, connectors, and single-use assemblies. Whether in biopharmaceutical fermentation or sterile injectables processing, fluid handling systems ensure containment, control, and hygiene at every stage. Selection of appropriate materials, surface finishes, and flow dynamics is essential to avoid contamination, material degradation, or process failure.

How Are Single-Use Systems and Automation Transforming Fluid Handling Practices?

Single-use fluid handling components are replacing traditional stainless-steel systems in many biopharmaceutical and sterile manufacturing environments. Pre-sterilized assemblies including tubing, bags, connectors, and filters reduce cleaning validation time and lower cross-contamination risks. These systems are particularly suitable for small-batch and multi-product facilities handling high-value or sensitive biologics.

Automated fluid transfer solutions with integrated sensors, flow meters, and digital control systems are enhancing process reliability. Use of closed-loop systems with real-time monitoring is increasing in upstream and downstream bioprocessing. Innovations such as pinch valves, aseptic quick connectors, and disposable pumps are further supporting precision handling. Compatibility with process analytical technologies (PAT) and compliance with good manufacturing practices (GMP) are critical design considerations across all equipment.

Where Is Demand Rising and What Processes Are Fueling Investment?

Fluid handling systems are essential across formulation, purification, fill-finish, and cleaning processes. Biopharmaceutical production, sterile injectable manufacturing, and vaccine formulation represent core areas of demand. Growing focus on high-throughput manufacturing and personalized medicine is driving investment in flexible, scalable fluid systems.

North America and Western Europe are mature markets with high adoption of automated and single-use systems. Asia-Pacific is expanding due to biomanufacturing growth, local vaccine production, and modernization of generic drug facilities. CDMOs are investing heavily in modular fluid handling systems that enable fast changeovers and compliance with global regulatory expectations.

Growth in the Pharmaceutical Fluid Handling market is driven by several factors…

Growth in the pharmaceutical fluid handling market is driven by increased production of biologics, expansion of sterile drug manufacturing, and transition toward single-use technologies. Rising adoption of modular manufacturing and process automation is pushing demand for integrated, closed-system fluid handling solutions.

Material innovations, including gamma-stable polymers and extractables-tested components, are enabling safer and more reliable liquid handling. Equipment designed for flexible scaling, multi-product compatibility, and regulatory compliance is supporting investment from both in-house manufacturers and contract facilities. Growing demand for faster production turnaround, reduced contamination risk, and enhanced process control is sustaining steady expansion in fluid handling infrastructure across global pharmaceutical manufacturing.

SCOPE OF STUDY:

The report analyzes the Pharmaceutical Fluid Handling market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Offering (Equipment & Solutions Offering, Services Offering); Tubing (Thermoplastic Elastomers Tubing, Polyvinyl Chloride Tubing, Silicone Tubing); Application (Fluid Handling & Management Application, Fluid Preparation Application, Integration & Automation Application, Buffer Management Application); Usage (Cough Syrup Usage, Intravenous Product Usage, Complex Active Pharmaceuticals Ingredients Usage)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Alfa Laval
• Bürkert Fluid Control Systems
• CPC (Colder Products Company)
• Crane Co.
• Danaher Corporation
• EMD Millipore (Merck Group)
• Endress+Hauser Group
• Entegris
• GEA Group
• GEMÜ Group
• IDEX Corporation
• Levitronix
• Masterflex (Avantor)
• Nordson Corporation
• Parker Hannifin Corporation
• PSG Dover
• Saint-Gobain Life Sciences
• Sartorius AG
• Swagelok Company
• Watson-Marlow (Spirax-Sarco)

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.